SOPHiA GENETICS SA Income from Discontinued Operations 2020-2025 | SOPH

SOPHiA GENETICS SA income from discontinued operations from 2020 to 2025. Income from discontinued operations can be defined as income or loss from the complete discontinuation of a segment or business, net of associated taxes and fees.

SOPHiA GENETICS SA Income from Discontinued Operations 2020-2025 | SOPH

SOPHiA GENETICS SA income from discontinued operations from 2020 to 2025. Income from discontinued operations can be defined as income or loss from the complete discontinuation of a segment or business, net of associated taxes and fees.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$45.6B
Doximity (DOCS)$11.7B
Hims & Hers Health (HIMS)$11.3B
Tempus AI (TEM)$9.7B
IRhythm Technologies (IRTC)$4.3B
Inspire Medical Systems (INSP)$3.8B
Hinge Health (HNGE)$3.6B
Privia Health (PRVA)$2.5B
Enovis (ENOV)$1.8B
Phreesia (PHR)$1.6B
Clover Health Investments (CLOV)$1.5B
10x Genomics (TXG)$1.5B
Schrodinger (SDGR)$1.5B
Azenta (AZTA)$1.5B
Evolent Health (EVH)$1.3B
Omnicell (OMCL)$1.3B
Claritev (CTEV)$717M
Fulgent Genetics (FLGT)$550M
Veradigm (MDRX)$536M
Standard BioTools (LAB)$463M
Butterfly Network (BFLY)$435M
Talkspace (TALK)$420M
TruBridge (TBRG)$321M
Outset Medical (OM)$320M
Nyxoah SA (NYXH)$270M
Health Catalyst (HCAT)$260M
CapsoVision (CV)$213M
Zepp Health (ZEPP)$203M
KORU Medical Systems (KRMD)$136M
American Well (AMWL)$125M